Clusterin silencing restores myoblasts viability and down modulates the inflammatory process in osteoporotic disease

Autor: Chiara Greggi, Monica Celi, Augusto Orlandi, Chiara Polidoro, Elena Gasbarra, Riccardo Iundusi, Giuseppe Novelli, Sabina Pucci, M. C. Piro, Maurizio Feola, Umberto Tarantino, Francesca Mastrangeli
Rok vydání: 2019
Předmět:
Zdroj: Journal of Translational Medicine
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-16 (2019)
ISSN: 1479-5876
Popis: Background Targeting new molecular pathways leading to Osteoporosis (OP) and Osteoarthritis (OA) is a hot topic for drug discovery. Clusterin (CLU) is a glycoprotein involved in inflammation, proliferation, cell death, neoplastic disease, Alzheimer disease and aging. The present study focuses on the expression and the role of CLU in influencing the decrease of muscle mass and fiber senescence in OP-OA condition. Methods Vastus lateralis muscle biopsies were collected from 20 women with OP undergoing surgery for fragility hip fracture and 20 women undergoing arthroplasty for hip osteoarthritis. Results We found an overexpression of CLU in degenerated fibers in OP closely correlated with interleukin 6 (IL6) and histone H4 acetylation level. Conversely, in OA muscle tissues we observed a weak expression of CLU but no nuclear histone H4 acetylation. Ex vivo studies on isolated human myoblasts confirmed CLU overexpression in OP as compared to OA (p
Databáze: OpenAIRE